White Paper

Operating A Pharmaceutical HVAC System In A Post COVID-19 Environment

By Louis Bruno, P.E., IPS

Corona COVID

The COVID-19 pandemic has forced pharmaceutical companies and other life sciences organizations to be extra vigilant in the sanitization of their facilities, specifically, in mitigating the transmission of COVID-19 and other respiratory illnesses in interior spaces — research laboratories, production facilities, office spaces, and more.

A vital aspect of this mitigation is the building heating, ventilation, and air conditioning (HVAC) system. Proper air circulation, particulate filtration, and humidity control all contribute to a cleaner, safer environment for employees and prevent sterile surfaces and materials in the building from being compromised.

This article examines how existing HVAC systems can be retrofitted – or new systems designed – to mitigate the airborne transmission of COVID-19 and other pathogens.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

IPS-Integrated Project Services